IP Library › Granted Patent US 9,551,701
Granted Patent B2
US 9,551,701 · App. 13/520,078 · Granted Jan 24, 2017

Method for detecting analyte in a bodily fluid, and dressing for implementing such a method

Inventors: Gilles Marchand (Pierre-Chatel, FR); Pierre Marcoux (Sassenage, FR)
Assignee: COMMISSARIAT À L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
G01N33/5088A61B5/00A61F13/0213A61F13/0226A61L15/56A61F13/0273A61F2013/00429A61F2013/00846A61F2013/00965
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,551,701
App. No.
13/520,078
Granted
Jan 24, 2017
Kind
B2
Abstract

A method for detecting an analyte in a bodily fluid includes placing the detector in contact with at least one metabolite resulting from the metabolism or degradation of the analyte. The contact between the detector and the metabolite produces an optically detectable signal. The detection method includes the detection of the metabolite only in gas form, said metabolite in gas form coming from the evaporation of at least a part of said metabolite. The detection is also carried out without contact between the bodily fluid and the detector. A dressing for implementing the detection method is also described.

Claims (39)

1. A method for detecting an analyte in a bodily liquid fluid, comprising:

placing a dressing in contact with a human or animal skin, said skin excreting said bodily liquid fluid, said bodily liquid fluid including said analyte, said dressing including at least a detector, said detector being located above the human or animal skin;

waiting for said analyte to either degrade or metabolize, and in doing so release a Volatile Organic Compound (VOC), said VOC released from the analyte being in a liquid form;

waiting for said liquid form of the VOC to evaporate into a gaseous organic compound; and

detecting said gaseous organic compound with said detector, wherein

said detector is an optical detector, where the optical detector is configured such that the presence of a gaseous form of the VOC modifies optical properties of the optical detector, and

said detector does not contact said bodily liquid fluid.

2. The method of claim 1 , wherein said analyte is a bacteria.

3. The method of claim 1 , wherein said optical detector is a chromogene detector, which color changes when contacting said gaseous form of the VOC.

4. The method of claim 1 , wherein said optical detector is a fluorogene detector, which produces a fluorescent emission when contacting said gaseous form of the VOC.

5. The method of claim 1 , wherein said detector includes a probe, which is specific

to a predetermined Volatile Organic Compound released by the analyte, or

to a predetermined class of Volatile Organic Compounds released by the analyte.

6. The method of claim 1 , wherein said detector is isolated from said bodily fluid by a protection element, which prevents any contact between said bodily fluid and said detector.

7. The method of claim 1 , wherein

said detector includes

a support, which is permeable to the gaseous form of the VOC, and

a probe, which is incorporated into the support, said probe being sensitive to the gaseous form of the VOC.

8. The method of claim 1 , wherein said detector comprises a probe, and said gaseous organic compound is detected via the probe selectively reacting with said gaseous organic compound.

9. A method for detecting an analyte in a bodily liquid fluid, comprising:

placing a dressing in contact with a human or animal skin, said skin excreting said bodily liquid fluid, said bodily liquid fluid including said analyte, said dressing including at least a detector, said detector being located above the human or animal skin,

degrading or metabolizing said analyte to release a Volatile Organic Compound (VOC), said VOC being in a liquid form; and

detecting a gaseous form of the VOC with said detector, when said liquid form of the VOC evaporates into said gaseous form of the VOC, wherein

said detector is an optical detector, where the optical detector is configured such that the presence of a gaseous form of the VOC modifies optical properties of the optical detector, and

said detector does not contact said bodily liquid fluid.

10. The method of claim 1 , wherein the detector includes a probe, where the probe is specific

to a predetermined Volatile Organic Compound released by the analyte, or

to a predetermined class of Volatile Organic Compounds released by the analyte, and

the probe is incorporated into the support by trapping, by adsorption or by covalent bonding.

11. The method of claim 10 , wherein the probe has one or more functions configured to interact with the predetermined Volatile Organic Compound released by the analyte such that, once bound to the predetermined Volatile Organic Compound released by the analyte, the probe produces an optically detectable signal.

12. The method of claim 11 , wherein the detection of said gaseous organic compound with said detector comprises forming an absorbing or fluorescent compound by reacting the probe with the gaseous form of the VOC.

13. The method of claim 1 , wherein the VOC in a liquid form that is released by the analyte is selected from the group consisting of ethanol, acetone, acetaldehyde, acetic acid, dimethyl sulfide, methane thiol, indole, aminoacetophenone, trimethylamine, hexanal, methanol, putrescine, cadaverine, CH 3 SH and cyclohexanone.

14. The method of claim 1 , wherein said detector includes a probe selected from the group consisting of 4-aminopent-3-in-2-one, dimethylaminobenzaldehyde, 4-dimethylaminocinnamaldehyde, cyclohexanone and acetaldehyde.

15. The method of claim 1 , wherein

said detector includes a probe comprising dimethylaminobenzaldehyde, and the gaseous organic compound is an indole;

said detector includes a probe comprising 4-dimethylaminocinnamaldehyde, and the gaseous organic compound is an indole;

said detector includes a probe comprising 4-aminopent-3-in-2-one, and the gaseous organic compound is an aldehyde;

said detector includes a probe comprising cyclohexanone, and the gaseous organic compound is 2′aminoacétophénone; or

said detector includes a probe comprising an aldehyde, and the gaseous organic compound is 2′aminoacétophénone.

Assignments (2)
RECORD TO CORRECT ASSIGNORS EXECUTION DATES ON AN ASSIGNMENT DOCUMENT PREVIOUSLY RECORDED ON JUNE 29, 2012, REEL (028466)/FRAME (0799) Recorded Jul 11, 2012
From: MARCHAND, GILLES; MARCOUX, PIERRE
To: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
Reel/Frame 028566/0296 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2012
From: MARCHAND, GILLES; MARCOUX, PIERRE
To: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
Reel/Frame 028466/0799 →
Priority Claims (1)
FR 10 00007 · Jan 4, 2010 · national
Continuity (1)
Related Publication 20120283529A1 · Nov 8, 2012